387 results match your criteria: "Reina Sofia Hospital[Affiliation]"
Front Med (Lausanne)
August 2023
Maimonides Institute for Biomedical Research of Córdoba (IMIBIC)/Reina Sofía Hospital/University of Córdoba, Córdoba, Spain.
Background: The obstructive sleep apnea syndrome (OSA) is a highly prevalent condition. In Spain and other countries, only 5%-9% of patients with OSA have been diagnosed and treated. The lack of accessibility to diagnosis is considered the main cause of this situation through easy-to-use screening instruments, it is necessary to check their validity and reliability in the context where they are to be used.
View Article and Find Full Text PDFGastroenterol Hepatol
May 2024
Department of Hospital Pharmacy, Reina Sofia Hospital of Murcia, Spain.
Background: Studies have investigated the efficacy and safety of switching to the biosimilar infliximab (CT-P13) in patients with inflammatory bowel disease (IBD). However, there is limited research directly comparing the effectiveness, drug survival, and pharmacokinetic profiles of the reference infliximab (IFX) and CT-P13 in real clinical settings.
Objective: To compare the effectiveness and drug survival of CPT-13 and reference IFX at weeks 26 and 52, and to determine the pharmacokinetic profiles and safety profile in real-world settings.
Hipertens Riesgo Vasc
March 2024
Internal Medicine, Andalussian Society of Autoimmune Diseases (AADEA), Spain.
Background: Cardiovascular disease (CVD) is one of the principal causes of death in antineutrophil cytoplasmic antibody-(ANCA)-associated vasculitis (AAV).
Objectives: To evaluate the mortality and it's causes and CVD and its vascular risk factors (VRFs) in AAV patients in Andalusia.
Methods: A multicenter cohort of 220 AAV patients followed-up from 1979 until June 2020 was studied in Andalussia, south of Spain.
Cancers (Basel)
July 2023
Department of Endocrinology and Nutrition, Reina Sofía Hospital, 31500 Córdoba, Spain.
Purpose: to perform an external validation of our predictive model to rule out pheochromocytoma (PHEO) based on unenhanced CT in a cohort of patients with PHEOs and adenomas who underwent adrenalectomy.
Methods: The predictive model was previously developed in a retrospective cohort of 1131 patients presenting with adrenal lesions. In the present study, we performed an external validation of the model in another cohort of 214 patients with available histopathological results.
Catheter Cardiovasc Interv
September 2023
Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK.
Background: The impact of intracoronary imaging on outcomes, after provisional versus dual-stenting for bifurcation left main (LM) lesions, is unknown.
Objectives: We investigated the effect of intracoronary imaging in the EBC MAIN trial (European Bifurcation Club LM Coronary Stent study).
Methods: Four hundred and sixty-seven patients were randomized to dual-stenting or a stepwise provisional strategy.
Free Radic Biol Med
October 2023
Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Campus de Excelencia Internacional Agroalimentario, CeiA3, Córdoba, Spain. Electronic address:
Cytochrome b reductase 3 (CYB5R3) activates respiratory metabolism in cellular systems and exerts a prolongevity action in transgenic mice overexpressing this enzyme, mimicking some of the beneficial effects of calorie restriction. The aim of our study was to investigate the role of sex on metabolic adaptations elicited by CYB5R3 overexpression, and how key markers related with mitochondrial function are modulated in skeletal muscle, one of the major contributors to resting energy expenditure. Young CYB5R3 transgenic mice did not exhibit the striking adaptations in carbon metabolism previously detected in older animals.
View Article and Find Full Text PDFRheumatology (Oxford)
March 2024
Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Objectives: Our primary objective was to quantify damage burden measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in aPL-positive patients with or without a history of thrombosis in an international cohort (the APS ACTION cohort). Secondly, we aimed to identify clinical and laboratory characteristics associated with damage in aPL-positive patients.
Methods: In this cross-sectional study, we analysed the baseline damage in aPL-positive patients with or without APS classification.
J Hosp Infect
August 2023
Spanish Society of Preventive Medicine, Public Health and Health Management, Spain.
Background: Surveillance of antimicrobial consumption is an important component of control strategies to tackle antimicrobial resistance.
Aim: To evaluate the consumption of antimicrobials using six indicators proposed by the European Center for Disease Prevention and Control.
Methods: Point prevalence survey data on antimicrobial use in Spanish hospitals throughout the period 2012-2021 were analysed.
EuroIntervention
May 2023
Department of Cardiology, Clinical Center of Serbia, and Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Provisional stenting has become the default technique for the treatment of most coronary bifurcation lesions. However, the side branch (SB) can become compromised after main vessel (MV) stenting and restoring SB patency can be difficult in challenging anatomies. Angiographic and intracoronary imaging criteria can predict the risk of side branch closure and may encourage use of side branch protection strategies.
View Article and Find Full Text PDFActa Psychiatr Scand
September 2023
Department of Psychology, University of Córdoba, Spain.
Introduction: Sex work is a common phenomenon, but socially invisible and stigmatized. Due to exposure to work-related risks, sex workers (SWs) are vulnerable to developing health problems. However, little attention has been paid to their mental health.
View Article and Find Full Text PDFJ Thromb Haemost
October 2023
Rheumatology Service, Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; Department of Cell Biology, Immunology and Physiology, Agrifood Campus of International Excellence, University of Córdoba, ceiA3, Córdoba, Spain; Cobiomic Bioscience SL, EBT University of Córdoba/IMIBIC, Córdoba, Spain. Electronic address: https://twitter.com/carlosps85.
Background: Nowadays little is known about the molecular profile of the occluding thrombus of patients with ischemic stroke.
Objectives: To analyze the proteomic profile of thrombi in patients who experienced an ischemic stroke in order to gain insights into disease pathogenesis.
Methods: Thrombi from an exploratory cohort of patients who experienced a stroke were obtained by thrombectomy and analyzed by sequential window acquisition of all theoretical spectra-mass spectrometry.
J Adv Nurs
June 2023
Department of Nursing, University of Murcia, Reina Sofía Hospital, Servicio Murciano de Salud (Murcian Health Service), ENFERAVANZA IMIB-Arrixaca, Investén-isciii, CIBERFES, Murcia, Spain.
Aim: To generate and understand the process of change in the empowerment of women from 60 to 80 years old through a Participatory Action Research.
Specific Aim: To analyse the women participants' experiences concerning empowerment and self-care.
Design: We use the Participatory Action Research approach (in its critical option) in the Socio-critical Paradigm and applying the Kemmis and McTaggart Model.
Ther Adv Med Oncol
January 2023
GEICAM Spanish Breast Cancer Group, Madrid, Spain.
Background: In the FLIPPER trial, palbociclib/fulvestrant significantly improved progression-free survival (PFS) compared with placebo/fulvestrant in postmenopausal women with HR+/HER2- advanced breast cancer (ABC).
Objective: We assessed health-related quality of life (QoL) using patient-reported outcomes (PROs).
Design And Methods: In this phase II double-blinded study, PROs were assessed at baseline after every three cycles and at the end of the treatment using the European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-BR23.
Catheter Cardiovasc Interv
February 2023
Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Brighton, UK.
Background: Techniques for provisional and dual-stent left main bifurcation stenting require optimization.
Aim: To identify technical variables influencing procedural outcomes and periprocedural myocardial infarction following left main bifurcation intervention.
Methods: Procedural and outcome data were analyzed in 438 patients from the per-protocol cohort of the European Bifurcation Club Left Main Trial (EBC MAIN).
Catheter Cardiovasc Interv
January 2023
Division of Cardiology, University of Washington, Seattle, Washington, USA.
Background: Coronary artery perforation is one of the most feared and common complications of chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Methods: To assess the usefulness of the recently developed PROGRESS-CTO (NCT02061436) perforation risk score in independent cohorts. Individual patient-level data pooled analysis of three registries was performed.
Rheumatology (Oxford)
August 2023
Rheumatology Department, Cochin Hospital, AP-HP. Centre, Paris, France.
Int J Cardiol
March 2023
Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address:
Background: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is associated with a considerable risk of complications, and risk stratification is of utmost importance.
Aims: To assess the clinical usefulness of the recently developed PROGRESS-CTO (NCT02061436) complication risk scores in an independent cohort.
Methods: Individual patient data pooled analysis of 3 registries was performed.
Am J Cardiol
February 2023
Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington. Electronic address:
Coronary artery perforation is one of the most common and feared complications of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We evaluated the utility of the recently presented OPEN-CLEAN (Coronary artery bypass graft, Length of occlusion, Ejection fraction, Age, calcificatioN) perforation score in an independent multicenter CTO PCI dataset. Of the 2,270 patients who underwent CTO PCI at 7 centers, 150 (6.
View Article and Find Full Text PDFEur J Cancer
December 2022
Vall d'Hebron University Hospital and Institute of Oncology (VHIO), CIBERONC, Barcelona, Spain.
Semin Arthritis Rheum
December 2022
University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Piazza del Donatore di Sangue 3, Turin 10154, Italy. Electronic address:
Thromb Res
December 2023
Department of Pneumology, Virgen del Rocio Hospital, Instituto de Biomedicina (IBIS)-CIBERES, Seville, Spain.
Introduction: Randomized controlled trials (RCTs) that conduct subgroup analyses have the potential to provide information on treatment decisions in specific groups of patients from heterogeneous populations. Although we understand several factors can modify the incidence of venous thromboembolism (VTE) and the benefit/risk ratio of anticoagulation treatments, further evidence is warranted to show the heterogeneity of treatment effects in different subgroups of patients.
Aims: The primary purpose was to evaluate the appropriateness and interpretation of subgroup analysis performed on VTE RCTs reporting pharmacological interventions.
Clin Cancer Res
January 2023
Medical Oncology Department, Hospital del Mar, Institut Mar Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, CIBERONC, Barcelona, Spain.
Purpose: Chemotherapy plus anti-EGFR is standard first-line therapy in RAS wild-type (wt) metastatic colorectal cancer (mCRC), but biomarkers of early response are clinically needed. We aimed to define the utility of ctDNA to assess early response in patients with mCRC receiving first-line anti-EGFR therapy.
Experimental Design: Prospective multicentric study of tissue patients with RAS wt mCRC treated with first-line chemotherapy plus cetuximab undergoing sequential liquid biopsies.
Eur J Cancer
October 2022
Centre Léon BERARD and University Claude Bernard Lyon 1, Lyon, and GINECO, France.
Background: PAOLA-1/ENGOT-ov25 (NCT02477644) demonstrated a significant progression-free survival (PFS) benefit with maintenance olaparib plus bevacizumab versus placebo plus bevacizumab in newly diagnosed, advanced ovarian cancer. We report the prespecified main second progression-free survival (PFS2) analysis for PAOLA-1.
Methods: This randomised, double-blind, phase III trial was conducted in 11 countries.
Prev Med Rep
October 2022
Community Activities Program in Primary Care (PACAP), Spanish Society for Family and Community Medicine (semFYC), Spain.
Health guidelines are important tools to ensure that health practices are evidence-based. However, research on how these guidelines are implemented is scarce. This integrative review aimed to: identify the literature on evaluation of public health guidelines implementation to explore (a) the topics which public health guidelines being implemented and evaluated in their implementation process are targeting; (b) how public health guidelines are being translated into action and the potential barriers and facilitators to their implementation; and (c) which methods are being used to evaluate their implementation.
View Article and Find Full Text PDFJACC Cardiovasc Interv
July 2022
Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea. Electronic address: